BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao L, Zhou L, Tian C, Li N, Shao W, Peng X, Shi Q. Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis. BMC Ophthalmol 2019;19:8. [PMID: 30621640 DOI: 10.1186/s12886-018-1016-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Rani PK, Das T. Evidence-based practice versus economics in treatment of macular edema secondary to central retinal vein occlusion in India. Eye (Lond) 2020;34:217-8. [PMID: 31767969 DOI: 10.1038/s41433-019-0709-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Gale R, Pikoula M, Lee AY, Denaxas S, Egan C, Tufail A, Taylor P; UK EMR Users Group. Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser. Br J Ophthalmol 2021;105:549-54. [PMID: 32532760 DOI: 10.1136/bjophthalmol-2020-315836] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Lin Y, Ren X, Chen D. Steroid Treatment in Macular Edema: A Bibliometric Study and Visualization Analysis. Front Pharmacol 2022;13:824790. [PMID: 35273502 DOI: 10.3389/fphar.2022.824790] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chhablani J, Wong K, Tan GS, Sudhalkar A, Laude A, Cheung CMG, Zhao P, Uy H, Lim J, Valero S, Ngah NF, Koh A. Diabetic Macular Edema Management in Asian Population: Expert Panel Consensus Guidelines. Asia Pac J Ophthalmol (Phila) 2020;9:426-34. [PMID: 32956188 DOI: 10.1097/APO.0000000000000312] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]